H7 BioCapital’s Post

🚀 Meet Our Advisors! We are excited to highlight that Nola E. Masterson, Venture Partner at Portfolia, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Nola E. Masterson "Nola has over 40 years of experience building and supporting biotech companies as an investor, entrepreneur, and consultant. She currently funds biotech ventures through Portfolia Femtech Funds. Her extensive background and commitment to advancing biotech innovation make her a key player in the industry." 🌷Apply now to learn invaluable insights from Nola E. Masterson and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel

As we look ahead to 2024, the biotech funding landscape is poised for evolution. ✨ Biotech startups have a range of funding avenues, all playing a pivotal role in fueling biotech innovation. Here's a glimpse: 🏢Government grants & public funding 💼Non-Government grants, 👤Private investment, 🦋Venture Capital, and 🤝Partnerships. You can guess our favorite. 😉 Accelerator programmes emerge as crucial catalysts. Programmes like ours offer not just funding but mentorship, resources, and a collaborative ecosystem, accelerating the path to success. 🙌 The biotech funding landscape is set for a thrilling evolution, and we 🦋 Labena Ventures are ready to be at the 😎 forefront of this dynamic journey. Join us on the fast track to groundbreaking discoveries! 📌 labenaventures.com/ Source: https://shorturl.at/qBELS . #startups #labenaventures #labena #accelerator #akcelerator #biotech #pharma #healthtech #food #founders #environment #bootcamp #investing #preseed #incubator #businessmentorship #cee #centralandeasterneurope #funding

💡 Are you a European HealthTech startup looking for funding? Heal Capital, one of Europe’s leading venture capital funds, is on the hunt for innovative digital health solutions! As part of our new "Investor Call" service on R2GConnect, they’re searching for startups from Pre-Seed to Series A with a focus on digital or data-driven healthtech. Here’s what you need to know: - Investment Size: €1-5 million - Focus Areas: Any therapeutic area - Region: Europe Want to learn more and apply? Click here: https://lnkd.in/ddCVG68g Investors: We invite you to explore R2GConnect.com and set up your own #InvestorCall for #free. For a demo session please reach out to Sorin STIRCU, Partnerships Manager https://bit.ly/3TGL2kF   #StartupFunding #VentureCapital #InvestorCall #HealthTechInvesting #EarlyStageInvesting #InvestmentOpportunities #DealFlow

🌐𝐒𝐨𝐟𝐢𝐧𝐧𝐨𝐯𝐚 𝐥𝐚𝐮𝐧𝐜𝐡𝐞𝐝 𝐧𝐞𝐰 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐟𝐨𝐫 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬🧬 𝐈𝐧 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟑, Sofinnova Partners a Venture capital 💰firm opens up #biotech creation ‘toolbox’ as a part of #Europe-wide strategy aimed at setting up and accelerating #biotechstartups across Europe. The strategy dubbed with #Biovelocita involves, newly formed #team 🤝assembled with aim of providing hand on combining #directmanagement, #robust framework for startups, #financialbanking 💲and also access to #Sofinnova’s extensive #network 📶and infrastructure. To improve and expand its creation-toolbox, Sofinnova partnered with group of experienced #investors and #entrepreneurs. ▶𝐎𝐭𝐡𝐞𝐫 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭:https://bit.ly/3uWv6AX #venturecapital #collaboration #buisnessstrategy #biotechcreation #biotech #prophecy #marketresearch #prophecymarketinsights

This Weeks 10 Biggest Funding Rounds (via @Crunchbase) 👍 This week witnessed another surge of substantial funding rounds, notably led by the biotech sector, with three startups securing positions in the top five. March appears to be continuing the trend set by February, with #investors demonstrating a growing willingness to invest significant sums in promising ventures. Read more: https://loom.ly/_eQ7M28 #vc #venturecapital #venturefunding #funding

🎉 Exciting News: Attention #DigitalHealth Startups! At R2GConnect, we’re launching a new "Investor Call" service and kicking things off with Heal Capital, one of Europe’s leading dedicated venture capital funds for integrated HealthTech. Heal Capital is on the lookout for: European HealthTech Startups | Pre-Seed to Series A If you’re building the next dominant #healthtech platform with a digital or data-driven approach and ambitious goals, they want to hear from you! #InvestmentSize: €1-5 million #FocusAreas: All therapeutic areas / Disease agnostic #Region: Europe Want to learn more and apply? Check it out here: https://lnkd.in/ddCVG68g Investors: We invite you to explore R2GConnect.com and set up your own #InvestorCall for #free. The platform enhances the efficiency of scouting, evaluating, and selecting the best HealthTech companies that match your investment interests. For a demo session please reach out to Sorin STIRCU, Partnerships Manager https://bit.ly/3TGL2kF   #StartupFunding #VentureCapital #InvestorCall #HealthTechInvesting #EarlyStageInvesting #InvestmentOpportunities #DealFlow

🚀 Meet Our Advisors! We are excited to highlight that Neil Littman, Founding Partner of Bioverge Ventures and Partner of Riverine Ventures, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 20th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 20th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Neil Littman "Neil Littman, M.S. is Founder & CEO of Bioverge Ventures, a venture capital firm exclusively dedicated to investing in #earlystage, #cuttingedge #healthcare companies. Bioverge’s investment thesis is focused on companies spanning the intersection of health + tech that are utilizing advances in technology to modernize healthcare, from bench-to-bedside." "Previously, Neil was Vice President of Business Development at Notable Labs, an oncology startup and Bioverge portfolio company, where he led the development of global corporate partnerships and contributed to the strategic vision of Notable as part of the Senior Leadership Team. Neil oversaw business development at Notable through the successful completion of the company’s $40 million Series B and was instrumental in negotiating multiple terms sheets to in-license clinical stage oncology assets." 🌷Apply now to learn invaluable insights from Neil Littman get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales

𝗠𝗲𝗱𝘁𝗲𝗰𝗵 𝗩𝗖 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗛𝗼𝗹𝗱𝘀 𝗦𝘁𝗿𝗼𝗻𝗴 𝗶𝗻 𝗤𝟮 💸📈💰 #Medtech startups continued to thrive in Q2, with #venturecapital investments showing solid performance according to PitchBook. The sector is on track to surpass last year's #VC figures significantly, and funding is gaining momentum, signalling long-awaited recovery for the industry. 💸 𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀: • In Q2, #Medtech venture capital secured $3.3 billion in deals, a 3.2% increase compared to the same period last year. • This marks the second consecutive quarter where deal activity outpaced the previous year. • Investment reached $6.8 billion in H1 2024, positioning the industry for nearly a 20% increase by year-end compared to 2023 • Key deals include significant transactions involving INSIGHTEC, BillionToOne, Kardium Inc., Karius, and DELFI Diagnostics. • Leading VC investors in medtech this quarter included the European Innovation Council Fund, SOSV, Alumni Ventures, and Arboretum Ventures. • #Privateequity activity also remained strong, with 28 buyouts and 19 growth deals recorded in Q2 #medtech #medicaldevices #executivesearch #recruitment #industrynews #vc #venturecapital #funding #startups #healthtech #dx #healthcare #startupfunding

💰 Uncover the Private Funding Landscape with AcademicLabs' Latest Updates! 💰 🚀 2000+ Investor Profiles: Discover a rich network of VCs and growth funds, with their investment criteria and portfolio startups. Navigate through our vast database to find key investors driving growth in your R&D area. 🐣 2500+ Incubator Profiles: Accelerate your early-stage innovations with our expansive selection of incubators, and their 21.000 portfolio startups. Dive into a world of resources and networks crucial for bringing new solutions to the market. 🔁 16K Portfolio Companies Linked to Investors and 21K to Incubators: Our intuitive ‘Wikipedia-like’ approach offers an in-depth view of the investment relationships in the R&D landscape. 🎯 Investor-Specific Filters: Cut through the noise and follow the money with precision. Our tailored filters allow you to sort by investment areas, ticket size, funding size, investment stage, and more. 👉 Book a demo on our website today, and save hours of time navigating the investment landscape in your field. #VentureCapital #Innovation #ResearchAndDevelopment #Growth #Investors #Incubators #Pharma #Biotech #Biotechnology #FundingLandscape #BiotechFunding #PharmaInnovation #Startups #InvestmentStrategy

Biotech startups often require substantial initial capital to support extensive research and development, clinical trials, and regulatory approvals before generating any revenue.   Our Investment Director, Michael Salako PhD MBA, recently spoke to Labiotech.eu, offering his advice to biotech startups trying to navigate the complex funding landscape.   When tackling the VC landscape, Michael advises biotech startups to be cautious and organised. “They should have a light touch non-confidential deck to send out and set the scene and a longer, more technical non-confidential deck that they can quickly talk to on a call if afforded the chance."   For more practical advice on choosing the right approach, read the full article here: https://rb.gy/smbt2h   #Biotech #StartUps #Funding #Fund #VentureBuilder